TY - JOUR
T1 - Cyclopentadienyl nitrosyl compounds of chromium
T2 - Aqueous solution chemistry, π bonding and nitric oxide loss
AU - Legzdins, Peter
AU - Rettig, Steven J.
AU - Smith, Kevin M.
AU - Tong, Vicki
AU - Young, Victor G.
PY - 1997/9/21
Y1 - 1997/9/21
N2 - The complex [Cr(η-C5H5)(NO)2(CF3SO 3)] 1 was synthesised in order to explore the relationship between π-donor ligands and nitrosyl lability and to investigate the aqueous chemistry of the [Cr(η-C5H5)(NO)2]+ fragment. Treatment of 1 with σ-donor ligands gave [Cr(η-C5H5)(NO)2(L)][CF3SO 3] salts. Potentiometric titrations and 1H NMR spectroscopic studies of 1 provided evidence for the existence of [Cr(η-C5H5)(NO)2(H2O)] + and [Cr(η-C5H5)(NO)2(OH)] in aqueous solution. When generated in situ, [Cr(η-C5H5)(NO)2(OH)] reacted with acetylacetone, pyridinecarboxylic acid, or salicylaldehyde to form paramagnetic, mononitrosyl complexes, which were independently synthesised from the mononitrosyl precursor [Cr(η-C5H5)(NO)(μ-I)]2. The solid-state molecular structures of [Cr(η-C5Me5)(NO)2(CF3SO 3)] 2, [Cr(η-C5H5)(NO)2(N2C 5H7)] 9 and [Cr(η-C5H5)(NO)(O2C5H 7)] 10 were determined by X-ray crystallography. Crystals of 2 are monoclinic, a = 8.575(1), b = 8.642(1), c = 21.8626(9) Å, β = 91.760(7)°, Z = 4, space group P21/n; crystals of 9 are monoclinic, a = 18.3382(4), b = 11.1774(3), c = 12.9102(1) Å, β = 121.386(1)°, Z = 8, space group C2/c; and those of 10 are orthorhombic, a = 17.373(2), b = 8.833(1), c = 6.926(2) Å, Z = 4, space group Pnma.
AB - The complex [Cr(η-C5H5)(NO)2(CF3SO 3)] 1 was synthesised in order to explore the relationship between π-donor ligands and nitrosyl lability and to investigate the aqueous chemistry of the [Cr(η-C5H5)(NO)2]+ fragment. Treatment of 1 with σ-donor ligands gave [Cr(η-C5H5)(NO)2(L)][CF3SO 3] salts. Potentiometric titrations and 1H NMR spectroscopic studies of 1 provided evidence for the existence of [Cr(η-C5H5)(NO)2(H2O)] + and [Cr(η-C5H5)(NO)2(OH)] in aqueous solution. When generated in situ, [Cr(η-C5H5)(NO)2(OH)] reacted with acetylacetone, pyridinecarboxylic acid, or salicylaldehyde to form paramagnetic, mononitrosyl complexes, which were independently synthesised from the mononitrosyl precursor [Cr(η-C5H5)(NO)(μ-I)]2. The solid-state molecular structures of [Cr(η-C5Me5)(NO)2(CF3SO 3)] 2, [Cr(η-C5H5)(NO)2(N2C 5H7)] 9 and [Cr(η-C5H5)(NO)(O2C5H 7)] 10 were determined by X-ray crystallography. Crystals of 2 are monoclinic, a = 8.575(1), b = 8.642(1), c = 21.8626(9) Å, β = 91.760(7)°, Z = 4, space group P21/n; crystals of 9 are monoclinic, a = 18.3382(4), b = 11.1774(3), c = 12.9102(1) Å, β = 121.386(1)°, Z = 8, space group C2/c; and those of 10 are orthorhombic, a = 17.373(2), b = 8.833(1), c = 6.926(2) Å, Z = 4, space group Pnma.
UR - http://www.scopus.com/inward/record.url?scp=33748662680&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33748662680&partnerID=8YFLogxK
U2 - 10.1039/a703595k
DO - 10.1039/a703595k
M3 - Article
AN - SCOPUS:33748662680
SN - 0300-9246
SP - 3269
EP - 3276
JO - Journal of the Chemical Society - Dalton Transactions
JF - Journal of the Chemical Society - Dalton Transactions
IS - 18
ER -